[Treatment of psoriasis arthropathica with bromocriptine].
35 patients suffering from psoriatic arthritis were systemically treated with bromocriptine at increasing doses, starting at 2.5 mg up to 30 mg per day. In 77% of the patients, we observed significant remission; 34% showed total remission and 43% remission of approximately 50% of the articular symptoms. Previous long-term treatment with commonly used anti-rheumatic drugs was not effective in any of the cases.
D000328:Adult; D000368:Aged; D001168:Arthritis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D001971:Bromocriptine / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007596:Joints / Q000000981:diagnostic imaging; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011877:Radionuclide Imaging
D001971:Bromocriptine
Zur Behandlung der Psoriasis arthropathica mit Bromocriptin.